Market Closed -
Nasdaq
16:00:00 2024-05-15 EDT
5-day change
1st Jan Change
3.45
USD
+0.58%
-6.25%
-35.51%
Presentation Operator MessageOperator (Operator)Thank you for standing by, and welcome to Harv...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024
05-07
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M
05-07
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
05-07
MT
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-07
CI
Harvard Bioscience, Inc. Provides Earnings Guidance for the Full Year 2024
05-07
CI
Harvard Bioscience Reducing Headcount
04-09
MT
Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
04-09
CI
Harvard Bioscience, Inc. Enters into A Third Amendment to the Credit Agreement
04-03
CI
Transcript : Harvard Bioscience, Inc., Q4 2023 Earnings Call, Mar 07, 2024
03-07
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 Revenue $28.2M
03-07
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04
03-07
MT
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2024
03-07
CI
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
03-07
CI
North American Morning Briefing : Powell Still in -2-
03-07
DJ
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications At Society of Toxicology Meeting
03-06
CI
Transcript : Harvard Bioscience, Inc., Q3 2023 Earnings Call, Nov 07, 2023
11-07
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q3 Revenue $25.4M
11-07
MT
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q3 EPS $0.01
11-07
MT
HARVARD BIOSCIENCE INC - REMAIN ON PATH TO REDUCING NET LEVERAGE…
11-07
RE
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-07
CI
Harvard Bioscience, Inc. Provides Revenue Guidance for the Year 2023
11-07
CI
Harvard Bioscience, Inc. to Showcase Latest Innovations in Preclinical and Organoid Research At Society for Neuroscience Conference
11-06
CI
Harvard Bioscience Unit Named as Exclusive Distributor of Etisense's Cardiorespiratory Monitoring Product
23-09-18
MT
Insider Buy: Harvard Bioscience
23-08-21
MT
Harvard Bioscience Seeks Acquisitions
23-08-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
More about the company
Last Close Price
3.45
USD
Average target price
7
USD
Spread / Average Target
+102.90%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**